Age-Related Macular Degeneration Archives

Roche’s Macular Degeneration Drug Hits Mark in Two Phase III Trials

Roche announced topline data from two identical Phase III trials (TENAYA and LUCERNE) of faricimab in neovascular or “wet” age-related macular degeneration (nAMD), with both studies hitting their primary endpoint.

U.S. Government Alleges Regeneron Used Kickbacks to Boost Eylea Sales

Regeneron Pharmaceuticals said the company will vigorously defend federal charges of being involved in a kickback scheme to bolster sales of the blockbuster macular degeneration drug Eylea.

Stealth Bio's neuromuscular disorder drug fails study

21st Century Cures Act, Age-Related Macular Degeneration, Barth Syndrome, Clinical Trials, Leber’s Hereditary Optic Neuropathy, Mitochondrial Disease, Mitochondrial Myopathy, Primary Mitochondrial Myopathy (PMM), Primary Mitochondrial Myopathy (PMM), Product Pipelines, R&D, Shares, Walking

Stealth BioTherapeutics Corp.’s shares crashed after the company’s lead neuromuscular disorder product candidate failed to help patients walk better and reduce fatigue.